Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Obstetrics & Gynaecology

Gynecologic Oncology

Association between genital mycoplasmas infection and human papillomavirus infection, abnormal cervical cytopathology, and cervical cancer: A systematic review and meta-analysis

Archives of Gynecology and Obstetrics | Evidence based | Mar 14, 2018 Gynecologic Oncology

Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: A retrospective analysis

Cancer Chemotherapy and Pharmacology | Mar 13, 2018 Gynecologic Oncology

Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer

The Breast | Mar 12, 2018 Gynecologic Oncology

Trastuzumab combined with doublet or single-agent chemotherapy as first-line therapy for HER2-positive metastatic breast cancer

Breast Cancer Research and Treatment | Mar 11, 2018 Gynecologic Oncology

First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM study

The Breast | Mar 11, 2018 Gynecologic Oncology

Tumor PIK3CA genotype and prognosis in early-stage breast cancer: A pooled analysis of individual patient data

Journal of Clinical Oncology | Mar 10, 2018 Gynecologic Oncology

Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer: Results from the NOWAC Study

Gynecologic Oncology | Mar 09, 2018 Gynecologic Oncology

The safety and feasibility of minimally invasive sentinel lymph node staging using indocyanine green in the management of endometrial cancer

European Journal of Obstetrics & Gynecology and Reproductive Biology | Mar 08, 2018 Gynecologic Oncology

Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): A randomised, phase 3 trial

The Lancet Oncology | Mar 07, 2018 Gynecologic Oncology

Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients

European Journal of Obstetrics & Gynecology and Reproductive Biology | Mar 07, 2018 Gynecologic Oncology

« Prev 1 … 108 109 110 111 112 … 143 Next »

Association between genital mycoplasmas infection and human papillomavirus infection, abnormal cervical cytopathology, and cervical cancer: A systematic review and meta-analysis

Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: A retrospective analysis

Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer

Trastuzumab combined with doublet or single-agent chemotherapy as first-line therapy for HER2-positive metastatic breast cancer

First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM study

Tumor PIK3CA genotype and prognosis in early-stage breast cancer: A pooled analysis of individual patient data

Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer: Results from the NOWAC Study

The safety and feasibility of minimally invasive sentinel lymph node staging using indocyanine green in the management of endometrial cancer

Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): A randomised, phase 3 trial

Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients

MIP: Snake Bite Management: Dr Surajit Giri

Therapeutic Effects of Bromelain: A Comprehensive Review

Anaemia: Types and Management

Neurological Emergencies: Recognising Essential Signs: MCQ challenge

Fluoride & its Administration

Association between genital mycoplasmas infection and human papillomavirus infection, abnormal cervical cytopathology, and cervical cancer: A systematic review and meta-analysis

Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: A retrospective analysis

Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer

Trastuzumab combined with doublet or single-agent chemotherapy as first-line therapy for HER2-positive metastatic breast cancer

First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM study

Tumor PIK3CA genotype and prognosis in early-stage breast cancer: A pooled analysis of individual patient data

Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer: Results from the NOWAC Study

The safety and feasibility of minimally invasive sentinel lymph node staging using indocyanine green in the management of endometrial cancer

Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): A randomised, phase 3 trial

Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients

MIP: Snake Bite Management: Dr Surajit Giri

Therapeutic Effects of Bromelain: A Comprehensive Review

Anaemia: Types and Management

Neurological Emergencies: Recognising Essential Signs: MCQ challenge

Fluoride & its Administration

Select Specialty

Select Topic